Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,539,470 papers from all fields of science
Search
Sign In
Create Free Account
ferumoxtran-10
Known as:
USPIO
, Ultrasmall Particulate Iron Oxide
, ferumoxtran
Expand
A substance being studied as a way of improving magnetic resonance imaging (MRI) in diagnosing cancer and finding lymph nodes to which cancer has…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Narrower (6)
AMI 227
BMS 180549
CLARISCAN
Combidex
Expand
Broader (3)
Contrast Media
Dextrans
Magnetite Nanoparticles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Ultrasmall Glutathione-Protected Gold Nanoclusters as Next Generation Radiotherapy Sensitizers with High Tumor Uptake and High Renal Clearance
Xiao-dong Zhang
,
Zhentao Luo
,
+11 authors
Jianping Xie
Scientific Reports
2015
Corpus ID: 2884012
Radiotherapy is often the most straightforward first line cancer treatment for solid tumors. While it is highly effective against…
Expand
Review
2012
Review
2012
Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles
Jing Huang
,
X. Zhong
,
Liya Wang
,
Lily Yang
,
H. Mao
Theranostics
2012
Corpus ID: 1885205
Engineering and functionalizing magnetic nanoparticles have been an area of the extensive research and development in the…
Expand
Highly Cited
2009
Highly Cited
2009
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder…
H. Thoeny
,
M. Triantafyllou
,
+6 authors
U. Studer
European Urology
2009
Corpus ID: 5432778
Highly Cited
2008
Highly Cited
2008
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek
,
A. Tsourkas
Biomaterials
2008
Corpus ID: 124365
Highly Cited
2008
Highly Cited
2008
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
R. Heesakkers
,
A. Hövels
,
+8 authors
J. Barentsz
The Lancet Oncology
2008
Corpus ID: 22222435
Review
2007
Review
2007
Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.
R. D. Bondt
,
P. Nelemans
,
+4 authors
R. Beets‐Tan
European Journal of Radiology
2007
Corpus ID: 41184204
Highly Cited
2006
Highly Cited
2006
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis.
O. Will
,
S. Purkayastha
,
+4 authors
P. Tekkis
The Lancet Oncology
2006
Corpus ID: 21838457
Highly Cited
2004
Highly Cited
2004
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz
,
G. Bonaterra
,
M. Rudelius
,
M. Settles
,
E. Rummeny
,
H. Daldrup-Link
European Radiology
2004
Corpus ID: 20496104
To evaluate the capacity of human monocytes to phagocytose various approved iron oxide based magnetic resonance (MR) contrast…
Expand
Highly Cited
2004
Highly Cited
2004
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.
S. Floris
,
Erwin L.A. Blezer
,
+6 authors
H. Vries
Brain : a journal of neurology
2004
Corpus ID: 9122165
Enhanced cerebrovascular permeability and cellular infiltration mark the onset of early multiple sclerosis lesions. So far, the…
Expand
Highly Cited
1998
Highly Cited
1998
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
M. Bellin
,
C. Roy
,
+10 authors
P. Cluzel
Radiology
1998
Corpus ID: 22086518
PURPOSE To evaluate the clinical and biologic safety of ultrasmall superparamagnetic iron oxide particles (AMI-227) as a contrast…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE